Drugs / Insulin Glargin
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT00523393 | Aug 2007 → Dec 2009 | type 2 diabetes mellitus | Heidelberg University | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin Glargin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00523393 ↗ |
| Known as | insulin glargine | “Patients were treated additionally with insulin glargine (n=20), NPH insulin (n=22) or escalated with oral medication (n=13).” PMID 25300286 ↗ Oct 2014 |
| Modality | Protein / enzyme biologic | “long acting insulin analogue Glargine” NCT00523393 ↗ |